1 study found for:    20810155 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Conditions: Hypereosinophilia;   Hypereosinophilic Syndrome
Intervention: Drug: mepolizumab

Indicates status has not been verified in more than two years